Cargando…

Dipeptidyl Peptidase‐4 Is a Pro‐Recovery Mediator During Acute Hepatotoxic Damage and Mirrors Severe Shifts in Kupffer Cells

Dipeptidyl peptidase‐4 (DPP‐4 or clusters of differentiation [CD]26) is a multifunctional molecule with established roles in metabolism. Pharmacologic inhibition of DPP‐4 is widely used to improve glycemic control through regulation of the incretin effect. Colaterally, CD26/DPP‐4 inhibition appears...

Descripción completa

Detalles Bibliográficos
Autores principales: Duarte, Nádia, Coelho, Inês, Holovanchuk, Denys, Inês Almeida, Joana, Penha‐Gonçalves, Carlos, Paula Macedo, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6128231/
https://www.ncbi.nlm.nih.gov/pubmed/30202822
http://dx.doi.org/10.1002/hep4.1225
_version_ 1783353613135904768
author Duarte, Nádia
Coelho, Inês
Holovanchuk, Denys
Inês Almeida, Joana
Penha‐Gonçalves, Carlos
Paula Macedo, Maria
author_facet Duarte, Nádia
Coelho, Inês
Holovanchuk, Denys
Inês Almeida, Joana
Penha‐Gonçalves, Carlos
Paula Macedo, Maria
author_sort Duarte, Nádia
collection PubMed
description Dipeptidyl peptidase‐4 (DPP‐4 or clusters of differentiation [CD]26) is a multifunctional molecule with established roles in metabolism. Pharmacologic inhibition of DPP‐4 is widely used to improve glycemic control through regulation of the incretin effect. Colaterally, CD26/DPP‐4 inhibition appears to be beneficial in many inflammatory conditions, namely in delaying progression of liver pathology. Nevertheless, the exact implications of CD26/DPP‐4 enzymatic activity in liver dysfunction remain unclear. In this work, we investigated the involvement of CD26/DPP‐4 in experimental mouse models of induced hepatocyte damage that severely impact Kupffer cell (KC) populations. Liver dysfunction was evaluated in CD26 knockout (KO) and B6 wild‐type mice during acute liver damage induced by acetaminophen, chronic liver damage induced by carbon tetrachloride, and KC‐depleting treatment with clodronate‐loaded liposomes. We found that necrosis resolution after hepatotoxic injury was delayed in CD26KO mice and in B6 mice treated with the CD26/DPP‐4 inhibitor sitagliptin, suggesting that DPP‐4 enzymatic activity plays a role in recovering from acute liver damage. Interestingly, the severe KC population reduction in acute and chronic liver injury was concomitant with increased CD26/DPP‐4 serum levels. Remarkably, both chronic liver damage and noninflammatory depletion of KCs by clodronate liposomes were marked by oscillation in CD26/DPP‐4 serum activity that mirrored the kinetics of liver KC depletion/recovery. Conclusion:CD26/DPP‐4 enzymatic activity contributes to necrosis resolution during recovery from acute liver injury. Serum CD26/DPP‐4 is elevated when severe perturbations are imposed on KC populations, regardless of patent liver damage. We propose that serum CD26/DPP‐4 is a potential systemic surrogate marker of severe impairments in the KC population imposed by clinical and subclinical liver conditions.
format Online
Article
Text
id pubmed-6128231
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-61282312018-09-10 Dipeptidyl Peptidase‐4 Is a Pro‐Recovery Mediator During Acute Hepatotoxic Damage and Mirrors Severe Shifts in Kupffer Cells Duarte, Nádia Coelho, Inês Holovanchuk, Denys Inês Almeida, Joana Penha‐Gonçalves, Carlos Paula Macedo, Maria Hepatol Commun Original Articles Dipeptidyl peptidase‐4 (DPP‐4 or clusters of differentiation [CD]26) is a multifunctional molecule with established roles in metabolism. Pharmacologic inhibition of DPP‐4 is widely used to improve glycemic control through regulation of the incretin effect. Colaterally, CD26/DPP‐4 inhibition appears to be beneficial in many inflammatory conditions, namely in delaying progression of liver pathology. Nevertheless, the exact implications of CD26/DPP‐4 enzymatic activity in liver dysfunction remain unclear. In this work, we investigated the involvement of CD26/DPP‐4 in experimental mouse models of induced hepatocyte damage that severely impact Kupffer cell (KC) populations. Liver dysfunction was evaluated in CD26 knockout (KO) and B6 wild‐type mice during acute liver damage induced by acetaminophen, chronic liver damage induced by carbon tetrachloride, and KC‐depleting treatment with clodronate‐loaded liposomes. We found that necrosis resolution after hepatotoxic injury was delayed in CD26KO mice and in B6 mice treated with the CD26/DPP‐4 inhibitor sitagliptin, suggesting that DPP‐4 enzymatic activity plays a role in recovering from acute liver damage. Interestingly, the severe KC population reduction in acute and chronic liver injury was concomitant with increased CD26/DPP‐4 serum levels. Remarkably, both chronic liver damage and noninflammatory depletion of KCs by clodronate liposomes were marked by oscillation in CD26/DPP‐4 serum activity that mirrored the kinetics of liver KC depletion/recovery. Conclusion:CD26/DPP‐4 enzymatic activity contributes to necrosis resolution during recovery from acute liver injury. Serum CD26/DPP‐4 is elevated when severe perturbations are imposed on KC populations, regardless of patent liver damage. We propose that serum CD26/DPP‐4 is a potential systemic surrogate marker of severe impairments in the KC population imposed by clinical and subclinical liver conditions. John Wiley and Sons Inc. 2018-09-07 /pmc/articles/PMC6128231/ /pubmed/30202822 http://dx.doi.org/10.1002/hep4.1225 Text en Copyright © 2018 The Authors. Hepatology Communications published by Wiley Periodicals, Inc., on behalf of the American Association for the Study of Liver Diseases. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Original Articles
Duarte, Nádia
Coelho, Inês
Holovanchuk, Denys
Inês Almeida, Joana
Penha‐Gonçalves, Carlos
Paula Macedo, Maria
Dipeptidyl Peptidase‐4 Is a Pro‐Recovery Mediator During Acute Hepatotoxic Damage and Mirrors Severe Shifts in Kupffer Cells
title Dipeptidyl Peptidase‐4 Is a Pro‐Recovery Mediator During Acute Hepatotoxic Damage and Mirrors Severe Shifts in Kupffer Cells
title_full Dipeptidyl Peptidase‐4 Is a Pro‐Recovery Mediator During Acute Hepatotoxic Damage and Mirrors Severe Shifts in Kupffer Cells
title_fullStr Dipeptidyl Peptidase‐4 Is a Pro‐Recovery Mediator During Acute Hepatotoxic Damage and Mirrors Severe Shifts in Kupffer Cells
title_full_unstemmed Dipeptidyl Peptidase‐4 Is a Pro‐Recovery Mediator During Acute Hepatotoxic Damage and Mirrors Severe Shifts in Kupffer Cells
title_short Dipeptidyl Peptidase‐4 Is a Pro‐Recovery Mediator During Acute Hepatotoxic Damage and Mirrors Severe Shifts in Kupffer Cells
title_sort dipeptidyl peptidase‐4 is a pro‐recovery mediator during acute hepatotoxic damage and mirrors severe shifts in kupffer cells
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6128231/
https://www.ncbi.nlm.nih.gov/pubmed/30202822
http://dx.doi.org/10.1002/hep4.1225
work_keys_str_mv AT duartenadia dipeptidylpeptidase4isaprorecoverymediatorduringacutehepatotoxicdamageandmirrorssevereshiftsinkupffercells
AT coelhoines dipeptidylpeptidase4isaprorecoverymediatorduringacutehepatotoxicdamageandmirrorssevereshiftsinkupffercells
AT holovanchukdenys dipeptidylpeptidase4isaprorecoverymediatorduringacutehepatotoxicdamageandmirrorssevereshiftsinkupffercells
AT inesalmeidajoana dipeptidylpeptidase4isaprorecoverymediatorduringacutehepatotoxicdamageandmirrorssevereshiftsinkupffercells
AT penhagoncalvescarlos dipeptidylpeptidase4isaprorecoverymediatorduringacutehepatotoxicdamageandmirrorssevereshiftsinkupffercells
AT paulamacedomaria dipeptidylpeptidase4isaprorecoverymediatorduringacutehepatotoxicdamageandmirrorssevereshiftsinkupffercells